Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B-cell Lymphoma

Explore clinical trials studying Diffuse Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

217 public trials 53 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B-cell Lymphoma trial results

Completed

Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.

NCT00355199

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Clinica di Ematologia - Nuovo Ospedale Torrette Ancona, Italy
  • U.O. Ematologia - Ospedali Riuniti di Bergamo Bergamo, Italy
  • Divisione di Ematologia - Ospedale Centrale di Bolzano Bolzano, Italy
  • CTMO - Ematologia - Ospedale "R. Binaghi" Cagliari, Italy
View all 16 locations
View Trial Details
Completed

Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

NCT00790036

Conditions
Diffuse Large B-cell Lymphoma, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations
  • Ironwood Cancer and Research Centers SC Chandler, Arizona, United States
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (3) La Jolla, California, United States
  • USC/Kenneth Norris Comprehensive Cancer Center Dept.ofNorrisMedicalCenter(4) Los Angeles, California, United States
View all 202 locations
View Trial Details
Completed

Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma

NCT01234467

Conditions
Diffuse Large B-cell Lymphoma, Diffuse Large-Cell Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations
  • Seby B. Jones Cancer Center Boone, North Carolina, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Northeast Medical Center Concord, North Carolina, United States
  • Moses Cone Regional Cancer Center Greensboro, North Carolina, United States
View Trial Details
Completed

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00075478

Conditions
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, +48 more
Locations
  • OHSU Cancer Institute-Southern Region Medford, Oregon, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details
Completed

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT01741792

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Universitätsmedizin Göttingen, Germany
  • Universitätsklinikum des Saarlandes Homburg, Germany
  • Universitätsklinikum Schleswig Holstein Kiel, Germany
  • Klinikum der Johannes-Gutenberg Universität Mainz, Germany
View Trial Details
Completed

Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007)

NCT00607854

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Service d'hématologie - CHU de Besançon Besançon, France
  • Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan Bordeaux - Pessac, France
  • Service d'hématologie - CHU Hôtel Dieu Clermont-Ferrand Clermont-Ferrand, France
  • Service de médecine nucléaire - Centre de Lutte contre le Cancer de la Région Auvergne Jean Perrin Clermont-Ferrand, France
View Trial Details
Completed

Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse

NCT01562990

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • AZ Sint Jan Bruges, Belgium
  • University Hospital Gent Ghent, Belgium
  • CHU Mont-Godinne Yvoir, Belgium
  • Hôpital Henri Mondor Créteil, France
View Trial Details
Completed

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT00831597

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Pharmatech Oncology Study Site Beverly Hills, California, United States
  • Pharmatech Oncology Study Site Fountain Valley, California, United States
  • Pharmatech Oncology Study Site Oxnard, California, United States
  • Pharmatech Oncology Study Site Washington D.C., District of Columbia, United States
View all 33 locations
View Trial Details

Related conditions